Abstract
Obesity is an important health problem because it is associated with diseases such as type 2 diabetes, hypertension, and hyperlipidemia in metabolic syndrome. The detail molecular mechanisms that underlie obesity have not been fully elucidated, and its therapeutic approach is of general interest. There is increasing evidence that obesity is under control of several factors in the brain and a number of studies have revealed that the brain functions that regulate energy balance play a central role in the development of obesity. Several orexigenic and anorexigenic neuropeptides in the brain are involved in obesity, although their relative contributions are different. The histamine-containing neurons and its receptors are distributed throughout the brain. The results of pharmacological studies revealed that neuronal histamine and its receptors are involved in the regulation of obesity in rodents and humans. In this review, we describe the neuronal histamine and its receptor as a pharmacological molecular target for obesity.
Keywords: Histamine, obesity, food intake, histamine H1 receptor, histamine H3 receptor
Current Molecular Pharmacology
Title: Molecular Mechanisms of Neuronal Histamine and its Receptors in Obesity
Volume: 2
Author(s): Takayuki Masaki and Hironobu Yoshimatsu
Affiliation:
Keywords: Histamine, obesity, food intake, histamine H1 receptor, histamine H3 receptor
Abstract: Obesity is an important health problem because it is associated with diseases such as type 2 diabetes, hypertension, and hyperlipidemia in metabolic syndrome. The detail molecular mechanisms that underlie obesity have not been fully elucidated, and its therapeutic approach is of general interest. There is increasing evidence that obesity is under control of several factors in the brain and a number of studies have revealed that the brain functions that regulate energy balance play a central role in the development of obesity. Several orexigenic and anorexigenic neuropeptides in the brain are involved in obesity, although their relative contributions are different. The histamine-containing neurons and its receptors are distributed throughout the brain. The results of pharmacological studies revealed that neuronal histamine and its receptors are involved in the regulation of obesity in rodents and humans. In this review, we describe the neuronal histamine and its receptor as a pharmacological molecular target for obesity.
Export Options
About this article
Cite this article as:
Masaki Takayuki and Yoshimatsu Hironobu, Molecular Mechanisms of Neuronal Histamine and its Receptors in Obesity, Current Molecular Pharmacology 2009; 2 (3) . https://dx.doi.org/10.2174/1874467210902030249
DOI https://dx.doi.org/10.2174/1874467210902030249 |
Print ISSN 1874-4672 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4702 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cystathionine Beta Synthase as a Risk Factor for Alzheimer Disease
Current Alzheimer Research Therapeutic Approaches for the Management of Sleep Disorders in Geriatric Population
Current Medicinal Chemistry Use of Cocktail Probe Drugs for Indexing Cytochrome P450 Enzymes in Clinical Pharmacology Studies – Review of Case Studies
Drug Metabolism Letters Pulmonary Hypertension and Lung Transplant in Connective Tissue Disease-Interstitial Lung Disease
Current Respiratory Medicine Reviews A Novel Strategy for Synthesis of Gold Nanoparticle Self Assemblies
Current Nanoscience Evaluation and Management of Atrial Fibrillation
Cardiovascular & Hematological Disorders-Drug Targets The Role of Endothelin-1 in Obstructive Sleep Apnea Syndrome and Pulmonary Arterial Hypertension: Pathogenesis and Endothelin-1 Antagonists
Current Medicinal Chemistry TNFα Modulation of Visceral and Spinal Sensory Processing
Current Pharmaceutical Design The Na+/H+ Exchanger: A Target for Cardiac Therapeutic Intervention
Current Drug Targets - Cardiovascular & Hematological Disorders Chronic Kidney Disease and Cardiovascular Disease: Is there Any Relationship?
Current Cardiology Reviews Dyslipidemia, Metabolic Syndrome and Vascular Disease Among Asian Indians
Vascular Disease Prevention (Discontinued) Secondary Metabolites in the Treatment of Diabetes Mellitus: A Paradigm Shift
Current Drug Metabolism Angiogenesis Inhibitors: Perspectives for Medical, Surgical and Radiation Oncology
Current Pharmaceutical Design Susceptibility Genes in Hypertension
Current Pharmaceutical Design Sulfur Dioxide: a Novel Gaseous Signal in the Regulation of Cardiovascular Functions
Mini-Reviews in Medicinal Chemistry Teaching a Lifestyle Intervention for Reversing Impaired Fasting Glucose, Hyperlipidemia and Obesity/Overweight to a Cohort of Local Physicians
Current Nutrition & Food Science Beta-Blockers use for Hypertension in the Elderly
Cardiovascular & Hematological Agents in Medicinal Chemistry Enhanced Risk for Specific Somatic Myeloproliferative Neoplastic Mutations in Patients with Stroke
Current Neurovascular Research Marinobufagenin in Urine: A Potential Marker of Predisposition to Ethanol and a Target for Spironolactone
Current Hypertension Reviews The Treatment of Behavioral and Psychological Symptoms of Dementia: Weighing Benefits and Risks
Current Alzheimer Research